Država: Irska
Jezik: engleski
Izvor: HPRA (Health Products Regulatory Authority)
Oxfendazole; Closantel
Norbrook Laboratories (Ireland) Limited
QP52AC52
Oxfendazole; Closantel
25/50 milligram(s)/millilitre
Oral suspension
POM: Prescription Only Medicine as defined in relevant national legislation
oxfendazole, combinations
Authorised
2003-06-30
Health Products Regulatory Authority 27 February 2019 CRN008TS7 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Parafend Plus Oral Suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCES Oxfendazole 2.5% w/v [25 mg/ml] Closantel 5.0% w/v [50 mg/ml] For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Oral suspension. An off white suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Sheep. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of mixed infections of mature and developing immature gastrointestinal roundworms, lungworms, tapeworms and fluke or sheep nasal fly in sheep and lambs. It is ovicidal against nematode eggs and delays egg laying in trematodes (fluke). The product is recommended for the treatment of mixed infections including: GASTROINTESTINAL ROUNDWORMS: _Ostertagia_ spp (adult, arrested and inhibited larvae) _Haemonchuscontortus _(adult, arrested and inhibited larvae) _Nematodirus_ spp (including _N.battus_) (adult and immature) _Cooperia_ spp (adult and immature) _Trichostrongylus_ spp (adult and immature) _Oesophagostomum_ spp (adult and immature) _Chabertia_ spp (adult and immature) LUNGWORMS: _Dictyocaulusfilaria_ (adult) TAPEWORMS: _Moniezia_ spp SHEEP NASAL FLY: _Oestrus ovis_ (larvae) FLUKES: Chronic and sub-acute fasciolosis due to _Fasciola hepatica_ (mature and late immature flukes). 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to the active ingredients. Health Products Regulatory Authority 27 February 2019 CRN008TS7 Page 2 of 5 Do not use in cases where infections with benzimidazole resistant species are suspected. In this case an appropriate narrow spectrum product should be used. The use of this product is contra-indicated in cases of known hypersensitivity to other benzimadazoles. (See sections 4.7 and 4.11) 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Care should be taken to avoid the following practices because th Pročitajte cijeli dokument